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AbstrACt
Introduction Polysomnography (PSG) is the primary tool 
for sleep monitoring and the diagnosis of sleep disorders. 
Recent advances in signal analysis make it possible 
to reveal more information from this rich data source. 
Furthermore, many innovative sleep monitoring techniques 
are being developed that are less obtrusive, easier to use 
over long time periods and in the home situation. Here, 
we describe the methods of the Sleep and Obstructive 
Sleep Apnoea Monitoring with Non- Invasive Applications 
(SOMNIA) project, yielding a database combining clinical 
PSG with advanced unobtrusive sleep monitoring 
modalities in a large cohort of patients with various 
sleep disorders. The SOMNIA database will facilitate 
the validation and assessment of the diagnostic value 
of the new techniques, as well as the development of 
additional indices and biomarkers derived from new and/or 
traditional sleep monitoring methods.
Methods and analysis We aim to include at least 2100 
subjects (both adults and children) with a variety of 
sleep disorders who undergo a PSG as part of standard 
clinical care in a dedicated sleep centre. Full- video PSG 
will be performed according to the standards of the 
American Academy of Sleep Medicine. Each recording 
will be supplemented with one or more new monitoring 
systems, including wrist- worn photoplethysmography and 
actigraphy, pressure sensing mattresses, multimicrophone 
recording of respiratory sounds including snoring, 
suprasternal pressure monitoring and multielectrode 
electromyography of the diaphragm.
Ethics and dissemination The study was reviewed by 
the medical ethical committee of the Maxima Medical 
Center (Eindhoven, the Netherlands, File no: N16.074). All 
subjects provide informed consent before participation.
The SOMNIA database is built to facilitate future research 
in sleep medicine. Data from the completed SOMNIA 
database will be made available for collaboration with 
researchers outside the institute.
IntroduCtIon
Although we spend about one- third of our 
lives sleeping, sleep is still one of the most 
mysterious human behaviours. Because of 
the unconscious nature of sleep, studying 
this behaviour depends heavily on tech-
nology. Since the discovery of the human 
electroencephalography (EEG) in 1929,1 this 
technique has been used to characterise the 
sleeping brain. In the mid- 1930s, different 
sleep stages were first described2 and only in 
1953 rapid eye movement (REM) sleep was 
formally described.3 In modern sleep medi-
cine, EEG is still the most important compo-
nent of polysomnography (PSG).4 With PSG, 
data about sleep stages and various physio-
logical measures, such as respiration, heart 
rate, leg movements and body position are 
acquired and analysed simultaneously to 
strengths and limitations of this study
 ► The Sleep and Obstructive Sleep Apnoea Monitoring 
with Non- Invasive Applications database will contain 
the gold standard in clinical sleep monitoring com-
bined with several new techniques to monitor sleep 
and sleep- related phenomena.
 ► We create a large dataset including both adults 
and children, covering the whole spectrum of sleep 
disorders.
 ► The focus of this database is on diverse (sleep) pa-
thologies and comorbidities, derived from a ‘real- 
world’ clinical setting.
 ► The size and variety of the dataset will make it a 
valuable source for a broad range of studies on 
sleep monitoring and diagnostics.
 ► The data will be available for collaboration on re-
search in sleep medicine.
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gain insight into sleep patterns and the presence of sleep 
disorders.
With the large number of PSG sensors, sleep registra-
tions contain a wealth of information. However, currently, 
this source is not used to its full potential. Although auto-
matic analyses are available, in clinical practice PSG is 
still typically scored manually by a skilled technician.5 
With the recent advances in signal analyses and machine 
learning, we are now capable of capturing even more 
complex information/patterns from the PSG.6 New 
parameters for diagnosis, symptom severity or clinical 
outcome might be found this way. Moreover, automatic 
detection of pathological phenomena is improving, such 
as sleep- related breathing events,7 8 movements related 
to movement disorders9 or nocturnal behaviour indica-
tive of parasomnia10 is improving. Both traditional PSG 
sensors and new devices can be used for this purpose. 
Large, well- characterised datasets containing divergent 
sleep pathologies are now needed to develop and validate 
these kinds of algorithms.11
Because of the complex setup, PSG has limitations. 
Subjects have to sleep with many sensors attached to their 
head and body, often in an unfamiliar hospital environ-
ment. This may cause stress or anxiety and influence the 
findings (first night effect).12 Many sleep disorders show 
night- to- night variation, so clinical events can easily be 
missed with only one night of observation. These draw-
backs are even more pronounced for the registration of 
sleep and sleep disorders in special populations, such 
as children, elderly and intellectually disabled subjects. 
These patients are easily intimidated by the large number 
of sensors and due to sensitive skin the use of contact 
sensors can be problematic. Furthermore, (visual) sleep 
scoring in these groups is more difficult and requires 
specific training.13
PSG remains the gold standard in sleep monitoring and 
diagnosis of sleep disorders, but many alternative tech-
niques are being developed. These include a wide range 
of sensing modalities including wearable sensors and 
sensor mattresses.14 These advanced techniques have in 
common that they are non- invasive and minimally obtru-
sive, and therefore better accepted by patients. Further-
more, they are easy to use over longer periods of time 
and applicable in the home situation. Possibly these inno-
vative solutions can play a role in treatment monitoring 
and the diagnosis of sleep disorders or eventually even 
substitute PSG in selected cases.
Application of sleep monitoring devices can roughly be 
divided into two categories: sleep staging and clinical event 
detection. Sleep stages are by definition based on EEG 
characteristics.4 However, surrogate measures based on 
movement or cardiorespiratory parameters are explored 
as well. Actigraphy is already a widely used measure for 
sleep/wake classification.15 The main application is to 
gain insight in rest- activity patterns over longer periods 
of time, for example, in case of (suspected) circadian 
rhythm disorders.4 Actigraphy has reasonable validity and 
reliability in healthy individuals with relatively good sleep 
patterns. However, the validity in special populations or 
in individuals with poor sleep or other sleep- related disor-
ders is more questionable.16
Recently, sleep staging algorithms based on cardiac 
and respiratory signals have shown promising results in 
healthy subjects.17 They are based on sleep- stage specific 
patterns in heart rate variability (HRV) and respiration.18 
These features can be derived from the ECG and respi-
ration belts, but also from photoplethysmography (PPG) 
signals, which can be incorporated in wearable devices.19 
Validation for this type of algorithms in patients is limited 
and has proven to be more challenging.20–22
Here, we describe the aims and methods of the Sleep 
and Obstructive Sleep Apnoea (OSA) Monitoring with 
Non- Invasive Applications (SOMNIA) project, which 
will yield a database containing clinical PSG combined 
with different advanced non- invasive sleep monitoring 
techniques in a large cohort of both adults and children 
with various sleep disorders from a tertiary referral sleep 
centre. Gold standard PSG will be augmented with a 
number of promising non- invasive monitoring systems, 
including wrist- worn PPG and actigraphy, pressure sensing 
mattresses, high fidelity acoustic recordings, suprasternal 
pressure monitoring and multielectrode electromyog-
raphy of the diaphragm. The additional technologies are 
chosen based on their unobtrusiveness, broad range of 
sensing approaches, potential clinical value and previous 
proof of concept and validation studies.19 23 24
An important focus of the SOMNIA database is on 
monitoring techniques for OSA, because this disorder 
is highly prevalent25 and has serious (potential) health 
consequences.26 27 Furthermore, in the current PSG 
montage, monitoring respiration requires the most 
obtrusive sensors.4 However, the database will also 
include insomnia, central disorders of hypersomnolence, 
circadian rhythm sleep- wake disorders, parasomnias, 
sleep- related movement disorders and cover as such the 
complete spectrum of sleep disorders, including complex 
and combined pathology.
The SOMNIA dataset can be used in several ways. First, 
it will allow validation of new sleep monitoring tech-
niques in a representative group of sleep clinic patients. 
Second, the diagnostic value of these different techniques 
can be assessed, as well as additional indices that can be 
derived by combining different new and/or traditional 
PSG techniques. Finally, the data can be used to study 
the physiology of sleep (disorders) in a cohort of patients 
including complex pathology and comorbidities. The 
SOMNIA database will be made available as a ‘neurophys-
iological biobank’, to enable multidisciplinary collabora-
tions to improve sleep diagnostics.
MEthods And AnAlysIs
Population
The SOMNIA database will be created within Sleep Medi-
cine Center Kempenhaeghe (Heeze, the Netherlands), 
a third- line expert centre for multidisciplinary sleep 
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medicine. Subjects are recruited among patients who 
are planned for a PSG as part of the standard diagnostic 
process. We aim to include 2000 adults and 100 chil-
dren with a variety of sleep disorders. We will include a 
minimum of 100 adults and 10 children per International 
Classification of Sleep Disorders (ICSD) diagnostic cate-
gory: insomnia, sleep- related breathing disorders, central 
disorders of hypersomnolence, parasomnias and sleep- 
related movement disorders. For the diagnosis of ICSD 
category circadian rhythm sleep–wake disorders, usually 
no clinical PSG is made, so we do not expect to include 
these patients as a separate group.
No formal exclusion criteria apply for this study. The 
overall goal of the study is to collect data of a repre-
sentative sample of a patient population in a dedicated 
sleep centre, so the dataset will include patients from 
the complete spectrum of (complex) sleep disorders. 
However, patients with very complex sleep pathology or 
particularly severe comorbidity will most likely not be 
included, because these patients have higher clinical 
demands and data may be too difficult to interpret and 
less useful in groupwise comparison studies. The decision 
whether or not to ask a patient for inclusion in the study 
will be made by the treating physician.
Typical numbers of clinical PSGs made per ICSD disorder 
category, per year for the recruiting centre are: 400 
insomnia, 850 sleep- related breathing disorders, 60 central 
disorders of hypersomnolence, 100 parasomnias and 200 
sleep- related movement disorders. With a practical estimate 
of 1:3 patients eligible for the study and willing to partici-
pate, we are planning 4 years for the study to run.
recruitment and general study procedure
Eligible patients who are scheduled for a PSG as part of 
usual medical care receive information about the study 
aims, procedures and the various additional sleep moni-
toring techniques. Depending on the technical utilities in 
the individually designated PSG bedroom, experimental 
sleep monitoring systems are added to the standard 
PSG. When it is not possible to add all sensors, a rele-
vant subset is chosen. Participation in the study may never 
lead to interference with the clinical PSG. Depending on 
the clinical question underlying the sleep assessment, 
patients will use their regular medication and/or Contin-
uous Positive Airway Pressure (CPAP) device during the 
sleep recording. All medication and other therapies are 
registered in the database.
Polysomnography
PSG registrations are made for one night. Patients stay 
at the inpatient clinic in an individual, sound- proof 
bedroom, under supervision of a sleep technologist.
Sleep is polysomnographically monitored using a dedi-
cated recording system (Grael PSG, Compumedics, USA). 
For technical details, see table 1. The primary sleep registra-
tion is based on the guidelines of the American Academy of 
Sleep Medicine (AASM),4 and consists of 6- channel EEG, 
2- channel electro- oculography and electromyography of 
the mentalis muscle. Polygraphy recordings include ECG, 
respiratory flow (nasal and oral thermistors), nasal pressure 
(nasal cannula), respiratory effort based on thoracoab-
dominal respiratory inductance plethysmography, oxygen 
saturation (transmissive finger PPG), snoring (piezoelectric 
tracheal microphone), body position (gravity- based electric 
sensor) and electromyogram (EMG) of tibialis anterior 
muscle. A time- synchronised video registration (infrared 
camera) is part of the standard recording. In selected 
cases based on a specific clinical question, additional 
measurements may be added; these include, for example: 
oesophageal pressure monitoring (eg, for suspected OSA 
while standard PSG was negative, or a clinical suspicion of 
both central and obstructive events), transcutaneous CO2 
measurements (eg, for a clinical suspicion of nocturnal 
hypoventilation) and additional EMG montages (eg, for 
suspected REM sleep behaviour disorder, propriospinal 
myoclonus or bruxism).
sleep and event scoring
Sleep and associated events are scored according to the 
AASM 2015 criteria5 using ProFusion software (ProFusion 
PSG V.4.00 (build 423), Compumedics, Australia). Respi-
ratory events, snoring and limb movements are automati-
cally scored by the software and subsequently checked and 
corrected by a certified sleep technician. All other events 
(eg, behaviour related to parasomnias or epilepsy, etc.) 
and sleep stages are scored by the technician without auto-
matic prescoring. When oesophageal pressure (PES) moni-
toring is used, PES events are scored manually. Full scoring 
of Respiratory Event Related Arousals is available when 
performed for diagnostic purposes on clinical grounds.
Clinical data
At intake, the clinician records primary clinical data 
including demographic information, current medication, 
comorbidities and the results of screening questionnaires 
(if applicable; Epworth Sleepiness Scale,28 Pittsburgh 
Sleep Quality Index,29 Insomnia Severity Index,30 Hospital 
Anxiety and Depression Scale,31 Checklist Individual 
Strength fatigue,32 Paris Arousal Disorders Severity Scale 
(PADDS)33). A final primary diagnosis is entered after the 
diagnostic trajectory for sleep pathology is finished. The 
diagnoses are coded according to the ICSD-2 criteria34 
which can be recoded according to ICSD-3 criteria4 
but contain some more subcategories especially in the 
insomnia category. Secondary sleep pathology and cate-
gories of comorbidities are also recorded.
Experimental measurement modalities
Wrist-worn PPG and actigraphy
This wrist- worn sensor is a CE- marked logging device 
combining reflective PPG and a three- axial accelerometer 
sensors (Philips Research, Eindhoven, the Netherlands). 
For technical details, see table 2. The logging device is 
mounted on the non- dominant wrist of the participant 
(same hand as the finger PPG sensor), with the sensor 
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Table 1 Technical specifications of the polysomnography (PSG) sensors
PSG measure Sensor Manufacturer Placement
Sampling 
frequency (Hz)
High- pass 
filter (Hz)
Low- pass 
filter (Hz)
EEG Ag/AgCl surface 
electrode
MFI B.V., the 
Netherlands
F4- M1, C4- M1, O2- 
M1, F3- M2. C3- M2, 
O1- M2 (according to 
international 10–20 
system)
256 0.3 70
EOG Ag/AgCl surface 
electrode
MFI B.V., the 
Netherlands
E1- M2 (E1: 1 cm below 
and 1 cm lateral to the 
left outer canthus), E2- 
M2 (E2: 1 cm above 
and 1 cm lateral to the 
right outer canthus)
256 0.3 70
EMG chin Ag/AgCl surface 
electrode
MFI B.V., the 
Netherlands
Chin 1: 2 cm below 
inferior edge of the 
mandible and 2 cm to 
the left of the midline
Chin 2: 2 cm below 
inferior edge of the 
mandible and 2 cm to 
the right of the midline
Chin 3: On the midline 
1 cm above inferior 
edge of the mandible
512 15 150
ECG Electrode H34SG, 
ECG +EEG EL 
46 mm
Kendall, Ireland Single modified 
electrocardiograph 
Lead II torso electrode 
placement
512 0.3 70
EMG tibialis Electrode H34SG, 
ECG +EEG EL 
46 mm
Kendall, Ireland Longitudinally on both 
legs and symmetrically 
in the middle of the 
anterior tibialis muscle 
2–3 cm apart
512 10 100
Airflow:         
Oronasal thermal 
airflow
SKU thermocouple 
airflow sensor
Compumedics, 
Australia
Infranasal 128 0.1 15
Nasal pressure 
transducer
Cannula 4000F, 
tube length 7 in
Salterlabs, USA Infranasal 128 0.1 15
Respiratory effort:         
Respiratory inductive 
plethysmography 
(RIP)
Dual thoracic 
abdominal RIP 
bands
Compumedics, 
Australia
Mid thorax and mid 
abdomen
128 0.1 15
Oesophageal 
manometry
Gaeltec CTO-1 
single sensor 
catheter
Gaeltec, Ireland Intraoesophageal, tip of 
pressure senor above 
the diaphragm
128 DC 15
Oxygen saturation:         
Transmissive PPG/
pulse oximetry
NONIN Purelight, 
flex sensor 8000J
Compumedics, 
Australia
Ring finger of the non- 
dominant hand
16 – –
Snoring:         
Condensor mic. 
sensor
Grael Tracheal 
Microphone
Compumedics, 
Australia
2 cm lateral to the 
cricothyriod cartilage
1024 10 100
Body position:         
Gravity- detecting 
electric sensor
Grael position 
sensor
Sleepsense, 
USA
Placed on the front of 
the thoracic RIP belt
16 – –
Continued
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PSG measure Sensor Manufacturer Placement
Sampling 
frequency (Hz)
High- pass 
filter (Hz)
Low- pass 
filter (Hz)
Transcutaneous CO2 SDMS Sentec, Swiss Earlobe (or forehead in 
children)
32 – –
Infrared video:         
Camera DinionHD 1080 p 
IP- camera
Bosch, Germany At the ceiling above the 
bed
– – –
Infrared light source Raymax50 Raytec, UK At the ceiling above the 
bed
– – –
EEG, electroencephalography; EMG, electromyogram; EOG, electro- oculogram; PPG, photoplethysmography; SDSM, SenTec Digital 
Monitoring System.
Table 1 Continued
Table 2 Technical specifications of the experimental monitoring devices
Device Manufacturer Placement
Sampling 
frequency
Synchronisation to 
PSG
Wrist- worn reflective 
PPG and actigraphy
Philips Research, 
the Netherlands
Non- dominant wrist, dorsal 
side of the hand, above the 
ulnar styloid process
PPG: 32 Hz
Accelerometer: 
128 Hz
Cross correlation with 
PSG recorded ECG/PPG 
interbeat intervals
Bed pressure sensor 2M Engineering, the 
Netherlands
Under the mattress: shoulder 
region, abdominal region, hip 
region (figure 1)
100 Hz Sync pulse every 10 min 
(via X- Link)
Acoustic signal 
registration:
        
M23 microphone (high 
end)
Earthworks, USA Top end of the bed, midline 
(figure 2)
48 kHz Continuous sync signal 
(via X- Link)
ECM8000 microphone Behringer, Germany Top end of the bed, sides 
(figure 2)
48 kHz Continuous sync signal 
(via X- Link)
Diaphragm 
electromyography
Electrode H34SG, 
ECG +EEG EL 
46 mm, Kendall, 
Ireland
In line in the sixth and seventh 
intercostal spaces; six on the 
frontal and two on the dorsal 
diaphragm. Reference on the 
sternum (figure 1)
512 Hz not applicable (recorded 
with PSG recorder)
Suprasternal pressure 
monitoring
        
Pressure sensor Sensym, 
SDX010IND4
Over the trachea in the sternal 
notch (figure 1)
128 Hz NA (recorded with PSG 
recorder)
Tracheostomy fixation Provox Optiderm 
Round 7255
      
Adapter 3D printed custom 
device
      
EEG, electroencephalography; PPG, photoplethysmography; PSG, polysomnography.
facing the skin on the dorsal side of the hand, above the 
ulnar styloid process (see figure 1).
The PPG logging device used in this project has been 
engineered to permit accurate PPG measurements, 
including the possibility to access data on beat- to- beat vari-
ability. Such measurements can be used to analyse HRV 
during the night, or to assess different cardiorespiratory 
parameters related to sleep.19 PPG algorithms have been 
developed to extract cardiac parameters such as average 
heart rate, HRV, as well as respiratory variables.19 35 36
The clocks of the PPG sensor and the PSG are 
synchronised by compensating the clock offset and drift, 
based on an interpolated (at 4 Hz) time series comprising 
the interbeat intervals detected from the PPG and 
another series from the interbeat intervals calculated 
from R- peaks detected from the ECG signal from the 
PSG. This guarantees that the recordings are perfectly 
aligned to the start time and that there is no clock drift 
between the two recorders.19
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Figure 1 Placement of the body- worn experimental 
sensors. Light grey circle: suprasternal pressure monitoring; 
Dark gray circle: diaphragm EMG; Dark square: wrist- worn 
photoplethysmography. EMG, electromyogram.
Figure 2 Microphone set- up at the top end of the bed. (A) 
Two microphones for high fidelity recordings (Earthworks 
M23) are placed at different heights at the midline of the 
bed. (B) Two microphones for average quality recordings 
(Behringer ECM8000) are placed at the same height at the 
sides of the bed and one on the night stand.
Bed pressure sensor
The bed sensor system (2M Engineering, the Nether-
lands) is a set of highly sensitive, optical pressure sensors 
located between the bed base and the mattress. Three 
independent, contact- free sensors record pressure 
changes to a local storage device with a sample frequency 
of approximately 100 Hz (see table 2). Each sensor regis-
ters global pressure changes in one zone of the bed. They 
are located under the shoulder region, under the abdom-
inal region and under the hip region. Large body move-
ments like bed occupancy and turning will be extracted 
from the recorded pressure signal.24 Besides large pres-
sure changes, the recorded signals also contain ballistic 
information about vital signs like breathing rate and 
heart rate.37 38
To postsynchronise the recorded data with the PSG 
data, a sync- pulse is stored locally but also sent from the 
bed sensor system to the PSG recording system every 
10 min.The sync- pulse is recorded by the PSG system 
using an additional device for external signals (X- link, 
Compumedics USA), and synchronised with the PSG 
signals by the PSG software. Time synchronisation with 
the bed sensor is achieved by cross correlating these sync 
pulse signals.
Audio recording for snoring analysis
Nocturnal sounds are recorded using five non- contact 
omnidirectional condenser measurement microphones 
(see table 2); two for high- quality recordings (Earthworks 
M23) and three for average quality recordings (Behringer 
ECM8000). The microphones are placed at different 
heights at the top end of the bed, 60–120 cm from the 
head (see figure 2). Signals are recorded by a digital field 
recorder (Zoom F8) with a sampling frequency of 48 kHz 
and a bit depth of 24.
To synchronise the sound and PSG recordings, a modu-
lated sinewave to yield a binary ‘code’ with a known time 
relation is generated using a USB development tool 
(C5505 eZdsp, Texas Instruments) and simultaneously 
fed to the audio recorder and PSG system using an addi-
tional device for external signals (X- link, Compumedics 
USA). The modulated sinewave is recorded synchro-
nously with the PSG signals by the PSG software. These 
recordings are cross correlated for time synchronisation.
Diaphragm electromyography
Monitoring the electric activity of the diaphragmatic and 
intercostal muscular system is the most direct way to obtain 
information on respiratory muscle function.39 Eight 
unipolar surface electrodes are symmetrically placed in 
line in the sixth and seventh intercostal spaces; six on the 
frontal and two on the dorsal diaphragm.40 The reference 
electrode is placed on the sternum (see figure 1). The 
extra EMG signals are recorded using direct input chan-
nels of the PSG recorder (see table 2).
Suprasternal pressure monitoring
For suprasternal pressure monitoring, a microphone is 
embedded in a cuff and placed over the trachea in the 
sternal notch.41 This device is used as a pressure trans-
ducer. Provided that the cuff is adequately sealed to the 
skin to ensure an airtight cavity, changes in intrathoracic 
pressure can be converted into a legible signal of respira-
tory effort.23
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Here, we use an in- house manufactured adaptation of 
the suprasternal pressure sensor based on a commercially 
available pressure sensor (Sensym, type: SDX010IND4), 
which is placed over the suprasternal notch and attached 
to the skin using a tracheostomy fixation adhesive (Provox 
Optiderm Round 7255). A custom- made 3D- printed 
adapter enables the pneumatic coupling to the pressure 
sensor. The signal is filtered and split into a respiratory 
signal and audio envelope. For respiration, the signal 
is limited by a low- pass 15 Hz filter while for removing 
cardiac artefacts an extra notch filter at 1.6 Hz is applied. 
For snoring, the signal is bandpass filtered between 30 
and 450 Hz and rectified after which the envelope is 
determined and the signal is dB scaled. The suprasternal 
pressure signals are recorded using direct input channels 
of the PSG recorder at a sampling rate of 128 Hz (band-
pass filter DC–35 Hz). In addition, the original unfiltered 
suprasternal pressure signal is also recorded as an extra 
channel (sampling rate 1024 Hz, bandpass filter DC–285 
Hz).
database
When the diagnostic trajectory is finished and the patient 
has received a final diagnosis based on the PSG, all clin-
ical and experimental data are combined. All data are 
converted to BioSemi Data Format,42 a 24- bit version of 
the 16- bit European Data Format ‘plus’ (EDF+). Sensor 
data are synchronised to the PSG and the data are trans-
ferred to the research database. Datasets that are exported 
for scientific research are pseudonymised using a study 
specific, unique coding, so different SOMNIA datasets 
cannot be related without the key file which is kept at 
Kempenhaeghe.
dIsCussIon
soMnIA opportunities
Here, we describe the aims and methods of the SOMNIA 
project, to create a large- scale database containing stan-
dardised PSG data and data from new, unobtrusive tech-
nologies to measure sleep (related) phenomena, in a 
real- world clinical setting. The current framework facili-
tates the validation of such new techniques and allows the 
diagnostic value of these techniques to be assessed, as well 
as the development of additional indices and biomarkers 
that can be derived by combining different new and/or 
traditional sleep monitoring methods. The large number 
of patients and wide variety of sleep disorders will make 
the SOMNIA database a valuable source for a broad range 
of studies on sleep monitoring and diagnostics.
Focus on diverse pathologies and comorbidities
Currently, there are several sleep databases available. For 
example, the Wisconsin Sleep Cohort (WSC),43 the Sleep 
Heart Health study (SHHS)44 and the Siesta database.45 
Both the WSC (n=1500) and SHHS (n=6600) are large 
population- based studies with a special focus on sleep- 
disordered breathing. The Siesta database is smaller and 
contains PSGs of 194 healthy subjects and 98 patients. 
The advantage of the SOMNIA database over the existing 
studies is that it is completely focused on patient data and 
all primary sleep disorders will be represented.
The SOMNIA data are acquired in a tertiary care 
referral centre, where a wide variety of (rare) sleep disor-
ders are diagnosed and treated. By integrating research 
into regular care, it is possible to include a large number 
of patients with various sleep disorders. All experimental 
techniques are non- invasive and non- minimally or mini-
mally obtrusive. The study requires no extra visits for the 
patient outside their regular care. Consequently, this study 
comprises no extra burden for the patient and almost 
all patients are eligible for participation. Also complex 
patients with multiple sleep disorders or comorbidities 
such as Parkinson’s disease, psychiatric or cardiovascular 
disorders will be included. For specific (combinations of) 
rare sleep disorders, it might be challenging to include 
large sample sizes in SOMNIA. However, it is important 
to have data from these patients available for validation 
studies aiming towards the general sleep clinic popula-
tion. This allows validation of new techniques in a ‘real- 
world’ clinical setting with its inherent variability and 
complexity. Furthermore, it provides the opportunity to 
study the influence of comorbid (sleep) disorders. For 
example, comorbid insomnia and OSA are gaining atten-
tion.46 47 However, in datasets collected in population 
studies or second- line sleep clinics, there are limited data 
available on this comorbid condition. The SOMNIA data-
base can be used to study the (patho)physiology of these 
complex patients in more detail.
Unobtrusive sensing technologies
Despite the technical revolution of the past decades, 
sleep medicine and sleep research still rely on relatively 
cumbersome diagnostic tools. For example, the diag-
nosis of OSA relies on several sensors to characterise the 
nature of sleep- disordered breathing. Measurements 
of respiration, nasal pressure, blood- oxygen saturation 
and respiratory effort are typical parts of the standard 
PSG montage. Respiration is the result of muscle activity 
that induces negative intrathoracic pressure and expan-
sion of the thoracic and abdominal cavities. Therefore, 
respiratory effort may be recorded from mechanical, 
electrical and electromechanical signals.23 The revised 
manual for the scoring of sleep and associated events by 
the AASM recommends the use of oesophageal manom-
etry or dual thoracoabdominal respiratory inductance 
plethysmography for this purpose.5 Especially, the first 
is an unpleasant procedure, which is often not very well 
tolerated by patients.48 Modern, less invasive sensing 
technologies such as wrist- worn reflective PPG, snoring 
analyses, diaphragm EMG and suprasternal pressure 
measurement all have the potential to capture respira-
tory characteristics of OSA specifically, and in general, 
physiological characteristics that might aid in the 
diagnosis, treatment and follow- up of sleep disorders. 
However, validation in a real- world clinical setting is 
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limited and the usefulness of these sensors in clinical 
practice remains unproven. These aspects are important 
because devices and algorithms that are developed for 
healthy users are not readily applicable to patients with 
sleep disturbances.22
Children
Paediatric sleep medicine is a young field of research and 
not many large- scale studies are available. We will make a 
specific effort to also include a significant number of chil-
dren in the SOMNIA database. There are essential differ-
ences between paediatric and adult patients. In children, 
other sleep disorders occur and sleep disorders can present 
themselves in a different way. For example, children do tend 
to have clinical symptoms of OSA with a much lower Apnoea 
Hypopnoea Index compared with adults.49 Moreover, 
obstructive events in children occur primarily during REM 
sleep .50 If an insufficient amount of REM sleep is captured 
during a PSG, for example, due to sleep disruption because 
of the uncomfortable monitoring equipment, the degree of 
OSA is likely to be underestimated. So, for this challenging 
group of patients, it is even more important to develop 
sleep monitoring techniques that are less obtrusive and 
intimidating. Furthermore, age is not only a determining 
factor in how long people sleep, it also has large influence 
on PSG characteristics, which is reflected in dedicated 
scoring rules for children and adolescents.13 Algorithms 
developed for analysis of adult sleep should be tested and 
probably adapted for the paediatric population. Although 
the sample sizes for paediatric patients will be much smaller 
than for adults, results from the SOMNIA database could 
give an indication for the potential usefulness of new non- 
obtrusive technologies or of adapted analysis algorithms. 
These could then be further validated in dedicated future 
studies, including directed efforts to obtain reference data.
In conclusion, with the SOMNIA project, we are creating 
a neurological database for advanced sleep monitoring in 
a clinical setting. The data can be used for a broad spec-
trum of studies, ranging from innovative PSG analyses to 
the validation of experimental sleep monitoring devices.
EthICs And dIssEMInAtIon
Ethics approval and consent to participate
According to the Dutch directives on research in human 
subjects, the study was reviewed by the medical ethical 
committee of the Maxima Medical Center (Eindhoven, 
the Netherlands, File no: N16.074). The study protocol 
was approved by the internal review boards of both the 
Kempenhaeghe Sleep Center (Heeze, the Netherlands) 
and Philips Research (Eindhoven, the Netherlands).
All subjects provide informed consent before partici-
pation. For the children, the information is given to the 
child as well as the parents (or legal guardians). Informed 
consent by both parents (or legal guardians) and children 
(age ≥12 years) is required in order to enter the study.
Availability of data and materials
The SOMNIA database is built to facilitate future research 
in sleep medicine. Data from the completed SOMNIA data-
base will be made available for collaboration with researchers 
outside the institute. To get access to the data, a researcher 
must submit a research protocol, with a clear scientific ques-
tion, to the Kempenhaeghe Center for Sleep Medicine. An 
internal review board will review the data request. When the 
study fits the vision of the SOMNIA project, the researcher 
will receive a pseudonymised copy of the requested data, to 
be used in that specific study. Specific restrictions apply to 
the availability of the data from the wrist- worn PPG sensor 
(Philips) and optical pressure sensor (2M Engineering), 
which are used under license and are not publicly avail-
able. These data are however available from the authors on 
reasonable request and with permission of Philips or 2M 
Engineering.
When the study is finished, the researcher returns the 
data. Kempenhaeghe will store the original dataset for at 
least 15 years.
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